AI Verdict
EW has stronger fundamentals based on our AI analysis.
EW vs GILD Fundamental Comparison
| Metric | EW | GILD |
|---|---|---|
| Revenue | $6.1B | $29.4B |
| Net Income | $1.1B | $8.5B |
| Net Margin | 17.7% | 28.9% |
| ROE | 10.4% | 37.5% |
| ROA | 7.8% | 14.4% |
| Current Ratio | 3.72x | 1.55x |
| Debt/Equity | 0.06x | 1.10x |
| EPS | $1.83 | $6.78 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
EW vs GILD: Frequently Asked Questions
Is EW or GILD a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), EW has stronger fundamentals. EW is rated BUY (85% confidence) while GILD is rated BUY (82% confidence). This is not investment advice.
How does EW compare to GILD fundamentally?
Edwards Lifesciences Corp has ROE of 10.4% vs GILEAD SCIENCES, INC.'s 37.5%. Net margins are 17.7% vs 28.9% respectively.
Which stock pays higher dividends, EW or GILD?
EW has a dividend yield of N/A or no dividend while GILD has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in EW or GILD for long term?
For long-term investing, consider that EW has BUY rating with 85% confidence, while GILD has BUY rating with 82% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about EW vs GILD?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For EW vs GILD, the AI consensus favors EW based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.